Occurence and clinical significance of MDM2 309T/G polymorphism in NSCLC patients from Northern Poland

A. Drozdowska, A. Szymanowska, E. Jassem, M. Niedoszytko, W. Rzyman, G. Gulida, J. Limon, J. Jassem (Gdansk, Poland)

Source: Annual Congress 2008 - Advances in functional genomics of neoplastic and non-neoplastic lung diseases
Session: Advances in functional genomics of neoplastic and non-neoplastic lung diseases
Session type: Thematic Poster Session
Number: 3546
Disease area: Thoracic oncology

Congress or journal article abstract

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
A. Drozdowska, A. Szymanowska, E. Jassem, M. Niedoszytko, W. Rzyman, G. Gulida, J. Limon, J. Jassem (Gdansk, Poland). Occurence and clinical significance of MDM2 309T/G polymorphism in NSCLC patients from Northern Poland. Eur Respir J 2008; 32: Suppl. 52, 3546

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
Occurrence and clinical significance of hOGG1 Ser326Cys polymorphism in NSCLC patients from northern Poland
Source: Eur Respir J 2006; 28: Suppl. 50, 812s
Year: 2006

Occurrence and clinical significance of hOGG1 Ser326Cys polymorphism in NSCLC patients from northern Poland
Source: Eur Respir J 2007; 30: Suppl. 51, 130s
Year: 2007

NAT2 gene polymorphism in lung cancer: A study from north India
Source: Annual Congress 2012 - Epidemiology of various respiratory diseases
Year: 2012


Association of -93G®A polymorphism in the hMLH1 gene with susceptibility to and prognosis of non-small cell lung cancer in Taiwan
Source: Eur Respir J 2006; 28: Suppl. 50, 151s
Year: 2006

ERCC1 and MDR1 expression and polymorphism frequency related to clinical outcome and chemotherapy response in a Brazilian sample of NSCLC patients
Source: Annual Congress 2013 –Systemic therapy of lung cancer and quality of life
Year: 2013

Association of GSTT1, GSTM1 and CYP1A1 MSP1 gene polymorphism with lung cancer patients in north Indian population
Source: Annual Congress 2010 - Epidemiology of lung cancer
Year: 2010

Arg72Pro P53 gene polymorphism is associated with P53 mutations in non-small cell lung cancer (NSCLC) patients
Source: Eur Respir J 2004; 24: Suppl. 48, 78s
Year: 2004

Association of GST gene polymorphism with the lung function of COPD patient in northern India population
Source: Annual Congress 2010 - Genetics of obstruction
Year: 2010

Association of XPD and CDA polymorphisms with clinical outcome in non-small cell lung cancer in a Chinese population
Source: Annual Congress 2012 - Prognosis of lung cancer
Year: 2012

Relationship of human papillomaviruses and codon 72 polymorphism in the TP53 gene with lung cancer in north of Iran
Source: Eur Respir J 2007; 30: Suppl. 51, 132s
Year: 2007

Arg72Pro P53 gene polymorphism as a predisposing factor for non-small cell lung cancer (NSCLC) development
Source: Eur Respir J 2004; 24: Suppl. 48, 78s
Year: 2004

LATE-BREAKING ABSTRACT: Association of GSTT1 & M1 gene polymorphism with ageing in Northern Indian COPD and lung cancer patients
Source: Annual Congress 2012 - COPD inflammation and genes
Year: 2012


Evaluation of EGFR mutations and ERCC2 polymorphisms in treatment of non-small cell lung cancer
Source: Annual Congress 2005 - Chemotherapy and palliative care
Year: 2005


Arg72Pro and GSTM1 gene polymorphisms increase the risk of non small cell lung cancer (NSCLC)
Source: Eur Respir J 2005; 26: Suppl. 49, 92s
Year: 2005

CYP1A1, GSTT1 and GSTM1 polymorphism in relation to lung cancer in eastern Poland
Source: Annual Congress 2008 - Advances in functional genomics of neoplastic and non-neoplastic lung diseases
Year: 2008

TP53 Arg72Pro, GSTM1, GSTP1 Ile105Val and GSTT1 gene polymorphisms as predisposing factors for non-small cell lung cancer (NSCLC) development
Source: Annual Congress 2006 - Molecular pathology and genetics of lung cancer
Year: 2006


CYP1A1 polymorphisms and risk of lung cancer in a Brazilian population
Source: Annual Congress 2008 - Advances in functional genomics of neoplastic and non-neoplastic lung diseases
Year: 2008

Genetic polymorphisms and lung cancer susceptibility in a Brazilian population
Source: Annual Congress 2008 - Advances in functional genomics of neoplastic and non-neoplastic lung diseases
Year: 2008

Analysis of XPD gene Lys751Gln polymorphism as predisposing factor for non-small cell lung cancer (NSCLC) development
Source: Eur Respir J 2007; 30: Suppl. 51, 131s
Year: 2007

Prognostic value of survivin gene promoter polymorphisms in non-small cell lung cancer
Source: International Congress 2016 – Prognostic variables in lung cancer I
Year: 2016